UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate at the following upcoming investor conferences:

Citi’s 14th Annual Biotech Conference

Date: September 4^th, 2019
Location: Boston, MA

Morgan Stanley 17th Annual Global Healthcare Conference

Date: September 10^th, 2019
Presentation Time: 8:00am
Location: New York, NY

A live audio webcast of the presentation at the Morgan Stanley Global Healthcare Conference will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITY

UNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Investors
Endurance Advisors 
Peter Rahmerprahmer@enduranceadvisors.com 

Media 
Jason Sparkjason@canalecomm.com

Source: Unity Biotechnology, Inc.